We are live on ! Find out more

24 hedge funds and large institutions have $6.72M invested in PAVmed in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,404% more capital inflows, than outflows

Capital inflows: $1.69M | Capital outflows: $67.6K

333% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 3

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

60% more funds holding

Funds holding: 15 → 24 (+9)

2.25% more ownership

Funds ownership: 6.28% → 8.53% (+2.3%)

Holders
24
Holders Change
+9
Holders Change %
+60%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
7
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

PAVM Hedge Fund Activity: Q1 2020 in Review

24 of the 4,550 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q1 2020, worth a combined $6.72M — up 110% from $3.2M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new PAVM positions and 3 closed out — a net gain of 10 holders — while 7 added to existing stakes and 2 trimmed.

The largest buyer was EAM Investors, opening a new position worth an estimated $791K. The largest seller was UBS Group, exiting entirely with an estimated $23K sold.

  • 24 institutional investors held PAVmed (PAVM) as of Q1 2020, up from 15 in Q4 2019.
  • Funds reported $6.72M of PAVmed stock for Q1 2020, up 110% quarter-over-quarter.
  • 13 funds opened new PAVmed positions in Q1 2020 and 3 closed out, a net change of +10 holders.
  • The largest PAVmed buyer in Q1 2020 was EAM Investors, an estimated $791K added.
  • The largest PAVmed seller in Q1 2020 was UBS Group, an estimated $23K sold.

Based on aggregated 13F filings for Q1 2020.